NCT02541396View on ClinicalTrials.gov

A Study Of The Effectiveness Of Wafermine Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Acute Pain
Interventions
DRUG

Wafermine

35 or 70 mg ketamine in a sublingual wafer

DRUG

Oxycodone

5 mg oxycodone capsule

DRUG

Placebo

Placebo capsule or placebo wafer

Trial Locations (1)

84124

Jean Brown Research, Salt Lake City

Sponsors

Collaborators (1)

Jean Brown Research
All Listed Sponsors
collaborator

Jean Brown Research

OTHER

lead

iX Biopharma Ltd.

OTHER